Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 38 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 1.2 to 0.6.
Financials
Financial year 2025
PHARMACIE SPELMANS from Liège, company number BE0677470665, closed financial year 2025 with a result of € 12,502 after tax. For that financial year PHARMACIE SPELMANS recorded a gross margin of € 136,434 and equity of € 119,788. Compared with financial year 2024, the result moved from € -6,463 to € 12,502. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 119,788
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 12,502
▲ still € 6,463 loss in 2024
Profit after tax over the fiscal year.
€ 46,723
▲ 33% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 113,588.
People and assets in 2025
0.6
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 42,674
▼ 20% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 13,651
▼ 39% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 120,241
▼ 23% vs 2024
€ 38,737 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 173,662
▼ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 10,831
▲ 18% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 154,239 | € 113,669 | € 129,320 | € 136,434 | ▲ 6% |
| Profit after taxes | € 65,027 | € -35,616 | € -6,463 | € 12,502 | ▲ € 18,965 |
| Equity | € 149,364 | € 113,748 | € 107,286 | € 119,788 | ▲ 12% |
| Total debts | € 844,862 | € 631,049 | € 602,426 | € 497,361 | ▼ 17% |
| Cash | € 158,800 | € 6,890 | € 35,211 | € 46,723 | ▲ 33% |
| Retained profit | € 143,164 | € 107,548 | € 101,086 | € 113,588 | ▲ 12% |
| Bank debt | € 234,382 | € 195,799 | € 156,552 | € 120,241 | ▼ 23% |
| Balance sheet total | € 994,226 | € 744,797 | € 709,712 | € 617,149 | ▼ 13% |
| Employees (FTE) | 0.3 | 1.2 | 0.8 | 0.6 | ▼ 0.2 |
By gross margin, PHARMACIE SPELMANS ranks 4th of 4 companies with main activity “Detailhandel in farmaceutische producten” in Liège that publish figures (fiscal year 2025).
Key figures of PHARMACIE SPELMANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMACIE SPELMANS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMACIE SPELMANS?
What happened at PHARMACIE SPELMANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 12,502. Source: NBB ↗
- New establishment in Liège. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 65,027 profit in 2022 to € 12,502 profit in 2025.
Paid € 599 in corporate taxes since 2022.
Best year ever: 2022, with € 65,027 profit.
On average € 94,700 of value added per employee in 2023.
Management
Behind PHARMACIE SPELMANS is Frédérique SPELMANS.
Directors
According to the 2025 annual accounts
Frédérique SPELMANS
Director
Establishments
Establishment units
Physical locations of this company
Rue de Beaufraipont 33 box B
4032 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Liège
Same main activity (Detailhandel in farmaceutische producten), 3 active companies in Liège, largest first.
€ 507,261 gross margin · 2025
€ 225,840 gross margin · 2025
€ 194,511 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- SPELMANS Frédérique Jeanne Marie Viviane Michelle(oprichter) 99.9%
- BLAIRVACQ Raphaël Pierre Jacqueline Jean Victor(oprichter) 0.1%
Details
- Company number
- 0677.470.665
- VAT number
- BE 0677.470.665
- Registered office
- Rue de Beaufraipont 33 bus B, 4032 Liège
- Names & denominations
- PHARMACIE SPELMANS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 June 2017
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten